Medical Devices Pre-Seed Investors & VC Firms
626 firms in this list, with a median first check of $250K. 158 of them lead rounds. Generated from verified public data and updated continuously.
WHYS Ventures
Beverly HillsPre-Seed–Growth
6 people
PFM Health Sciences
San FranciscoPre-Seed–Series A
10 people
Skolkovo Startup Academy / accelerator
MoscowPre-Seed–Seed
10 people
Paipal Ventures
Pre-Seed–Series A
Seed Fonds Aachen
AachenPre-Seed–Series A$545K – $2.2M
1 person
Southeast Minnesota Capital Fund
RochesterPre-Seed–Series A
4 people
NextFab Ventures
PhiladelphiaPre-Seed–Seed
East Post Road Ventures
Pre-Seed–Series A
4 people
Longevity Venture Partners
BaltimorePre-Seed–Series A
4 people
M ACCELERATOR
Los AngelesPre-Seed–Seed$1M – $5M
6 people
New Orleans BioFund
New OrleansPre-Seed–Seed$500K
6 people
the Untitled Ventures
LuxembourgPre-Seed–Series A
6 people
Bif
HamburgPre-Seed–Series A
4 people
Archetype Ventures
TokyoPre-Seed–Series A
6 people
Jumar Bioincubator
MelbournePre-Seed–Seed
9 people
Aurora Science
MilanoPre-Seed–Series A$1.1M – $5.4M
5 people
Dalton Venture
ShanghaiPre-Seed–Series A
8 people
K2VC
BeijingPre-Seed–Series A
7 people
Ballad Ventures
Johnson CityPre-Seed–Series B$500K – $1.5M
3 people
AmorChem
MontréalPre-Seed–Series A
5 people
Louisiana Funds
Baton RougePre-Seed–Seed
3 people
MedTech Entrepreneurs (MTE)
GraefelfingPre-Seed–Series A$540K – $3.2M
5 people
1921 Ventures
ViennaPre-Seed–Series A$200K – $1.5M
1 person
TEXO Ventures
AustinPre-Seed–Series A
4 people
Related lists
Pre-Seed Investors & VC Firms (5993)Pre-Seed Investors & VC Firms in North America (3332)Pre-Seed Investors & VC Firms in United States (2970)AI & Machine Learning Pre-Seed Investors & VC Firms (2596)Fintech Pre-Seed Investors & VC Firms (2035)SaaS Pre-Seed Investors & VC Firms (1902)Pre-Seed Investors & VC Firms in Global (1833)Medical Devices Investors & VC Firms (1814)Pre-Seed Investors & VC Firms in Europe (1780)Healthtech Pre-Seed Investors & VC Firms (1741)
Data sourced from public filings and firms' own websites — see our methodology.























































